Cooney MT - Search Results

1

Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary.

Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, Beheiry HM, Champagne B, Connell K, Cooney MT, Ezeigwe N, Gaziano TA, Gidio A, Lopez-Jaramillo P, Khan UI, Kumarapeli V, Moran AE, Silwimba MM, Rayner B, Sukonthasan A, Yu J, Saraffzadegan N, Reddy KS, Khan T. Al-Makki A, et al. Among authors: cooney mt. Hypertension. 2022 Jan;79(1):293-301. doi: 10.1161/HYPERTENSIONAHA.121.18192. Epub 2021 Nov 15. Hypertension. 2022. PMID: 34775787 Free PMC article.

2

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.

WHO CVD Risk Chart Working Group. WHO CVD Risk Chart Working Group. Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. doi: 10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2. Lancet Glob Health. 2019. PMID: 31488387 Free PMC article.

3

Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.

Cooney MT, Dudina A, Whincup P, Capewell S, Menotti A, Jousilahti P, Njølstad I, Oganov R, Thomsen T, Tverdal A, Wedel H, Wilhelmsen L, Graham I; SCORE Investigators. Cooney MT, et al. Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):541-9. doi: 10.1097/HJR.0b013e32832b38a1. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19773660

4

Assessment of cardiovascular risk.

Cooney MT, Cooney HC, Dudina A, Graham IM. Cooney MT, et al. Among authors: cooney hc. Curr Hypertens Rep. 2010 Oct;12(5):384-93. doi: 10.1007/s11906-010-0143-1. Curr Hypertens Rep. 2010. PMID: 20838940 Review.

5

Determinants of coronary artery disease risk factor management across three world regions.

Zhao M, Graham I, Cooney MT, Grobbee DE, Vaartjes I, Klipstein-Grobusch K. Zhao M, et al. Among authors: cooney mt. Heart Asia. 2019 Mar 8;11(1):e011112. doi: 10.1136/heartasia-2018-011112. eCollection 2019. Heart Asia. 2019. PMID: 31031827 Free PMC article.

6

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Cooney MT, Dudina AL, Graham IM. Cooney MT, et al. J Am Coll Cardiol. 2009 Sep 29;54(14):1209-27. doi: 10.1016/j.jacc.2009.07.020. J Am Coll Cardiol. 2009. PMID: 19778661 Free article. Review.

7

Do novel biomarkers add to existing scores of total cardiovascular risk?

De Backer G, Graham I, Cooney MT. De Backer G, et al. Among authors: cooney mt. Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):14-7. doi: 10.1177/2047487312448988. Eur J Prev Cardiol. 2012. PMID: 22801065 Review.

8

Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?

Cooney MT, Dudina A, D'Agostino R, Graham IM. Cooney MT, et al. Circulation. 2010 Jul 20;122(3):300-10. doi: 10.1161/CIRCULATIONAHA.109.852756. Circulation. 2010. PMID: 20644026 Review. No abstract available.

9

Total cardiovascular disease risk assessment: a review.

Cooney MT, Cooney HC, Dudina A, Graham IM. Cooney MT, et al. Among authors: cooney hc. Curr Opin Cardiol. 2011 Sep;26(5):429-37. doi: 10.1097/HCO.0b013e3283499f06. Curr Opin Cardiol. 2011. PMID: 21822139 Review.

10

SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP working group and ESC Cardiovascular risk collaboration. Eur Heart J. 2021 Jul 1;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312. Eur Heart J. 2021. PMID: 34120185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page